Tamoxifen doesn't alter endometrial cancer outcome
Key points
- For breast cancer patients who later developed endometrial cancer, prior treatment with tamoxifen does not reduce the chances of survival, researchers report.
- Women with breast cancer also have an increased risk for cancer of the endometrium, the lining of the uterus, Dr.
- Anderson Cancer Center in Houston, analyzed data on 89 women who developed endometrial cancer after surviving breast cancer.
- Clinically, endometrial cancer was similar in tamoxifen users and non-users, the investigators found.
For breast cancer patients who later developed endometrial cancer, prior treatment with tamoxifen does not reduce the chances of survival, researchers report.
Women with breast cancer also have an increased risk for cancer of the endometrium, the lining of the uterus, Dr. Karen H. Lu and colleagues note in the July issue of Obstetrics and Gynecology. While tamoxifen is effective in preventing breast cancer and its recurrence, the drug's effect on prognosis when endometrial cancer occurs has been unclear.
To investigate, Lu's team, from M. D. Anderson Cancer Center in Houston, analyzed data on 89 women who developed endometrial cancer after surviving breast cancer. Forty-six of the patients had taken tamoxifen.
Clinically, endometrial cancer was similar in tamoxifen users and non-users, the investigators found. Moreover, there was no significant difference between the groups in mortality overall or specifically due to endometrial cancer.
However, the interval from breast cancer to endometrial cancer diagnosis averaged 77.2 months in tamoxifen users, whereas the interval in nonusers was 121.3 months, Lu and colleagues report.
SOURCE: Obstetrics and Gynecology, July 2004.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsFertility Tx May Alter Cancer Risk
The unsuccessful use of fertility drugs was associated with a reduced risk of young-onset breast cancer, although women who did go on to conceive saw an increased risk for the disease, according to researchers. In a…
15 July 2012
NewsMolecular subtypes and genetic alterations may determine response to lung cancer therapy
Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient's individual molecular profile. But scientists are finding that in many types of cancer the…
13 May 2012
NewsPSA screening doesn't prevent cancer deaths: study
Annual screening for prostate cancer doesn't cut men's chances of dying from the disease, according to the latest results of a large screening trial. Comparing men who were screened each year with so-called PSA tests,…
8 January 2012
